Wang Lai 4
4 · BeOne Medicines Ltd. · Filed Jun 15, 2026
Research Summary
AI-generated summary of this filing
BeOne (ONC) President Wang Lai Receives RSUs; Sells Shares
What Happened Wang Lai, President and Global Head of R&D at BeOne Medicines (ONC), received two restricted share unit (RSU) awards on June 11, 2026 totaling 348,400 shares (118,625 and 229,775), each recorded as acquisitions at $0.00. On the same date he disposed of 756 American Depositary Shares (ADSs) in an open-market sale at a weighted average price of $261.00, generating $197,318. The sale was effected to satisfy mandatory tax withholding tied to a vesting event.
Key Details
- Transaction date: June 11, 2026 (Form 4 filed June 15, 2026).
- Awards: 118,625 RSUs (F1) and 229,775 RSUs (F10); combined 348,400 RSUs granted at $0.00. One grant is reported as a derivative award.
- Sale: 756 ADSs sold; weighted average price $261.00 (range $260.87–$261.16 per F8); proceeds $197,318. Sale made pursuant to mandatory tax withholding (F7).
- Vesting: F1 — 25% vests each anniversary of June 11, 2026; F10 — 25% on first anniversary of June 11, 2026, then remaining shares vest in 36 equal monthly installments. Unvested RSUs may accelerate on certain termination events.
- ADS / ordinary share note: Each ADS represents 13 ordinary shares (F6).
- Shares owned after transaction: Not specified in the filing.
- Filing timeliness: No indication in this filing that it was late.
Context RSU awards are compensation grants that vest over time and do not require an immediate cash outlay by the executive; they are more of a retention/compensation signal than a direct market purchase. The small sale reported here was a routine, mandatory withholding sale to cover taxes on RSU vesting (not a discretionary stock sale for investment purposes). Additional footnotes (F2–F5) describe other holdings and an RMB-share employee participation plan in which the reporting person participated; those notes clarify indirect economic interests and conversion mechanics for Shanghai STAR Market shares.
Insider Transaction Report
Form 4
Wang Lai
President, Global Head of R&D
Transactions
- Award
Ordinary Shares
[F1]2026-06-11+118,625→ 1,710,085 total - Sale
American Depositary Shares
[F6][F7][F8]2026-06-11$261.00/sh−756$197,318→ 0 total - Award
Share Option (Right to Buy)
[F9][F10]2026-06-11+229,775→ 229,775 totalExercise: $20.81Exp: 2036-06-10→ Ordinary Shares (229,775 underlying)
Holdings
- 601,965(indirect: See Footnote)
Ordinary Shares
[F2] - 0(indirect: See Footnote)
RMB Shares
[F3][F4][F5]
Footnotes (10)
- [F1]Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 11, 2026, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
- [F10]These securities vest over a four-year period as follows: 25% on the first anniversary of June 11, 2026 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
- [F2]These securities are held by Wang Holdings LLC, the limited liability company interests of which are owned by the Reporting Person, his spouse and a trust created by the Reporting Person for the benefit of his spouse and children, for which the Reporting Person disclaims beneficial ownership.
- [F3]The term "RMB Shares" is used herein to represent the ordinary shares, par value $0.0001 per share, of the Issuer, issued directly by the Issuer in the Issuer's initial public offering on the Science and Technology Innovation Board (the "STAR Market") of the Shanghai Stock Exchange (the "STAR Offering"), to permitted investors in Renminbi ("RMB") within the People's Republic of China ("PRC") in accordance with the rules of the STAR Market.
- [F4]The Issuer established an employee participation program ("RMB Shares Employee Participation Plan"), which allows certain executive officers and qualified employees of the Issuer's subsidiaries in the PRC to indirectly participate in the STAR Offering and purchase certain RMB Shares from the Issuer through an asset management plan administrated by China International Capital Corporation Limited in a transaction that is exempt under Rule 16b-3. The RMB Share Employee Participation Plan purchased an aggregate of 2,069,546 RMB Shares directly from the Issuer in the STAR Offering at the initial public offering price of RMB192.6 per RMB Share (or $30.1295 based on an assumed exchange rate of $1.00 = RMB6.3924).
- [F5]The Reporting Person, as an individual participant in the RMB Shares Employee Participation Plan, has contributed RMB10 million to the RMB Shares Employee Participation Plan. The Reporting Person may be deemed to have indirect economic interest in an indeterminable portion of the RMB Shares held by the RMB Shares Employee Participation Plan but does not have voting or dispositive power over any of such shares. The Reporting Person disclaims Section 16 beneficial ownership of the RMB Shares held by the RMB Shares Employee Participation Plan, except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such RMB Shares for Section 16 or any other purpose.
- [F6]Each American Depositary Share represents 13 Ordinary Shares.
- [F7]The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.87 to $261.16, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- [F9]The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.
Signature
/s/ Qing Nian, as Attorney-in-Fact|2026-06-15